Globus Medical (GMED) Receivables Refunds (2016 - 2025)
Globus Medical (GMED) has disclosed Receivables Refunds for 15 consecutive years, with $64.7 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Receivables Refunds rose 213.71% year-over-year to $64.7 million, compared with a TTM value of $64.7 million through Dec 2025, up 213.71%, and an annual FY2025 reading of $64.7 million, up 213.71% over the prior year.
- Receivables Refunds was $64.7 million for Q4 2025 at Globus Medical, down from $69.0 million in the prior quarter.
- Across five years, Receivables Refunds topped out at $69.0 million in Q3 2025 and bottomed at $366000.0 in Q1 2024.
- Average Receivables Refunds over 5 years is $13.9 million, with a median of $3.3 million recorded in 2022.
- The sharpest move saw Receivables Refunds soared 2043.21% in 2021, then plummeted 87.97% in 2024.
- Year by year, Receivables Refunds stood at $1.2 million in 2021, then surged by 234.24% to $4.1 million in 2022, then plummeted by 59.74% to $1.6 million in 2023, then surged by 1161.96% to $20.6 million in 2024, then skyrocketed by 213.71% to $64.7 million in 2025.
- Business Quant data shows Receivables Refunds for GMED at $64.7 million in Q4 2025, $69.0 million in Q3 2025, and $48.6 million in Q2 2025.